INTRODUCTION
Mutational activation of oncogenes and mutational inactivation of tumour suppressor genes have been shown to be key elements in multistage carcinogenesis. We have used variants of the mouse JB6 epidermal cell to investigate the complicated molecular mechanisms of tumorigenesis. The JB6 cell lines were originally established from untreated Balb\c primary epidermal cell cultures and consist of three phenotypically distinct clonal cell variants : (i) promotion-resistant (P − ) cells that are resistant to tumourpromoter-induced transformation (Cl30.7b), (ii) promotion-sensitive (P + ) cells that are sensitive to tumour-promoter-induced transformation (Cl22 and Cl41), and (iii) P + -derived neoplastically transformed (Tx) cells (RT101) [1] . This system, therefore, has permitted the study of preneoplastic progression (P − to P + ) and preneoplastic-to-neoplastic progression (P + to Tx) in tumourpromoter-induced transformation [1] [2] [3] . The molecular mechanism for tumorigenesis in the JB6 model is partially understood. P + cells display activator protein-1 (AP-1)-dependent tumourpromoter-inducible transactivation of gene expression, whereas P − cells have a defect in AP-1 transactivation [4] . Elevated AP-1 activation appears to be required for both the induction and maintenance of tumour phenotype, as blocking of AP-1 produces reversion to earlier stages [5] . Neither point mutation of the Hras or p53 genes nor structural alterations in p53 are involved in tumorigenesis in JB6 cells [3] .
By using the recently developed technique of differential mRNA display [6] , five differentially expressed clones were isolated from JB6 cell variants [7] . Interestingly, one of these mRNAs was specifically expressed in preneoplastic JB6 (P − and Abbreviation used : TIMP-3, tissue inhibitor of metalloproteinases-3 ; hTIMP-3, human TIMP-3 ; mTIMP-3, mouse TIMP-3 ; P − and P + cells, JB6 cells that are resistant and sensitive respectively to tumour-promoter-induced transformation ; AP-1, activator protein-1 ; EMSA, electrophoretic mobility shift assay ; TRE, PMA (' TPA ')-responsive element ; SV40, simian virus 40 ; NF-κB, nuclear factor-κB.
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spanning AP-720 has the highest transcriptional activity, and that sequences 5h to this region (nt k2846 to k747) may contain negative regulatory elements. The deletion construct containing about 500 nt 5h to the transcriptional start, but no AP-1 sites, showed lower but significant activity, suggesting both AP-1-dependent and -independent regulation of the mouse TIMP-3 promoter. Mutational inactivation of AP-720 abolished the activity increment that distinguished the reporter construct containing both AP-720 and sixth AP-1 binding site (AP-617 ; nt k617 to k611) from that containing only AP-617. In summary, we report here that both AP-1 and non-AP-1 elements contribute to activity, with the non-consensus AP-1 site at k720 showing the greatest functional significance among the AP-1 sites.
P + ) cells, but was not expressed in multiple neoplastic (Tx) cells. This isolated clone showed 96 % amino acid sequence identity to the recorded sequence of human tissue inhibitor of metalloproteinases-3 (hTIMP-3) and 100 % identity to mouse TIMP-3 (mTIMP-3). Matrix metalloproteinases are zinc-containing enzymes that are involved in the degradation of the extracellular matrix, and the activities of these proteinases are controlled by specific inhibitors such as the TIMPs [8] . Three members of the TIMP family have been reported and have been shown to regulate matrix degradation as well as the suppression of tumorigenicity or invasion in several model systems [9] [10] [11] [12] . TIMP-1 and TIMP-2 are relatively well characterized, while hTIMP-3 [13] [14] [15] [16] [17] [18] and mTIMP-3 [7, [19] [20] [21] [22] have been more recently cloned and identified. Unlike TIMP-1 and TIMP-2, TIMP-3 is an extracellular-matrix-associated protein with a distinct pattern of expression [16, [20] [21] [22] [23] [24] .
The fact that mTIMP-3 transcripts are expressed in preneoplastic but not neoplastic mouse JB6 cells suggests a role for mTIMP-3 in neoplastic progression in this system. The lack of expression of mTIMP-3 in neoplastic JB6 cells is due neither to mutation of the gene nor to lack of transcription factors [22] . Altered methylation of the mTIMP-3 gene may contribute to the complete down-regulation of gene expression seen in neoplastic cells [22] . However, the mechanism by which this gene is regulated in cells that express mTIMP-3 is currently unknown. Recently we have cloned the full-length mTIMP-3 cDNA and the promoter of the gene [22] . Sequencing of 2.9 kb upstream of the mTIMP-3 transcriptional start site revealed six AP-1 or AP-1-like binding sites (k1958 to k1950, k1348 to k1342, k1117 to k1111, k763 to k754, k720 to k714 and k617 to k611) [22] . In the present paper, we have addressed questions concerning the functional activities of these AP-1 binding sites in the regulation of the mTIMP-3 promoter. This is, to our knowledge, the first reported attempt to carry out a careful analysis of a TIMP-3 promoter with respect to specific DNA elements. The results show that only a subset of these AP-1 sites appears to be functional for both sequence-specific protein binding and transcriptional activation, and that non-AP-1 sites are important as well.
MATERIALS AND METHODS

Cell culture
Mouse JB6 cells were cultured in Eagle's minimal essential medium (Whittaker, Walkersville, MD, U.S.A.) containing 5 % (v\v) fetal calf serum. The cell doubling times for P − (Cl30.7b) and P + (Cl22 and Cl41) cells are approx. 28 and 24 h respectively. NIH 3T3 mouse fibroblasts were grown in Dulbecco's modified Eagle's medium with 10 % (v\v) fetal calf serum (BRL, Gaithersburg, MD, U.S.A.). For AP-1-mediated transcriptional assays, cells were seeded in 24-well plates 16 h prior to transfection. Approx. 4i10% cells per well were used to achieve optimal transfection efficiency.
DNase I footprinting analysis
mTIMP-3 promoter sequence probes of approx. 300 nt were prepared by the PCR and were 5h-end-labelled to high specific radioactivity on the top strand only. Approx. 1i10& c.p.m. of radiolabelled probe was incubated with or without 250 ng of purified c-Jun protein (Promega, Wisconsin, WI, U.S.A.) in 50 µl of footprinting buffer (25 mM Tris\HCl, pH 8, 50 mM KCl, 6.25 mM MgCl # , 0.5 mM EDTA, 10 % glycerol and 0.5 mM dithiothreitol) for 30 min on ice. A 50 µl aliquot of a solution containing 5 mM CaCl # and 10 mM MgCl # was then added, and the samples were incubated at room temperature for 1 min. The samples were treated with 3 µl of DNase I solution (50 units\ml) for 1 min at room temperature, after which the reaction was terminated by the addition of 90 µl of stop buffer (200 mM NaCl, 30 mM EDTA, 1 % SDS and 100 µg\ml yeast tRNA). The samples were then extracted with phenol\chloroform and ethanol-precipitated. The digestion products were resolved on a 6 % sequencing gel. Appropriate sequencing ladders were run in adjacent lanes.
Electrophoretic mobility shift assay (EMSA)
EMSAs were performed with nuclear protein extracts prepared from JB6 cells under the conditions described [25] . The simian virus 40 (SV40) AP-1-containing consensus sequence from the SV40 promoter (5h-CTAGTGATGAGTCAGCCGGATC-3h) (Stratagene, La Jolla, CA, U.S.A.) and recombinant c-Jun protein (Promega) were used as positive controls. The mSV40 oligonucleotide (5h-CTAGTGACGAGTGAGCCGGATC-3h) was identical with the SV40 oligonucleotide, except that the T in position 8 [position 1 of the PMA (' TPA ')-responsive element (TRE)] was changed to a C, and the C in position 13 (position 6 of the TRE) was changed to a G. The corresponding changes were also made in the complementary oligonucleotide. The nuclear factor-κB (NF-κB) oligonucleotide (5h-CTTGGGACTTTCCT-ACGGCTAAA-3h) was used as a competitor. In addition, six oligonucleotides that represent the six AP-1 or AP-1-like binding sites in the mTIMP-3 promoter were synthesized. The first (k1958 to k1950), second (k1348 to k1342), third (k1117 to Second (k1348/k1342) AP-1348 5h-AGGGATGCTGAGTCAGGGATGTA-3h 3h-TCCCTACGACTCAGTCCCTACAT-5h
Third (k1117/k1111) AP-1117 5h-CAGAAGCCTGACTCAGGAAGATC-3h 3h-GTCTTCGGACTGAGTCCTTCTAG-5h
Fourth (k763/k754) AP-763 5h-TTCTGGCATGATGTCACATCTTT-3h 3h-AAGACCGTACTACAGTGTAGAAA-5h
Fifth (k720/k714) AP-720 5h-ACGCCCTCTTAGTCATTCTAACC-3h 3h-TGCGGGAGAATCAGTAAGATTGG-5h
Sixth (k617/k611) AP-617 5h-AGGGTCTGTTGAATAATTCCACA-3h 3h-TCCCAGACAACTTATTAAGGTGT-5h k1111), fourth (k763 to k754), fifth (k720 to k714) and sixth (k617 to k611) binding sites were designated AP-1958, AP-1348, AP-1117, AP-763, AP-720 and AP-617 respectively ( Table 1 ). The oligonucleotides used for EMSA are also shown in Table 1 . All oligonucleotides were annealed in equimolar amounts (50 ng\µl) and end-labelled with [γ-$#P]ATP (Amersham, Arlington Heights, IL, U.S.A.) using polynucleotide kinase (Boehringer Mannheim, Indianapolis, IN, U.S.A.). Unincorporated oligonucleotides were removed by using a Sephadex G-25 column (Boehringer Mannheim). Portions of 3 µg of nuclear protein extracts from P + cells were incubated with 3 µg of anti-AP-1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, U.S.A.) and 1 µg of poly(dI-dC) (Boehringer Mannheim) in binding reactions containing 40 mM Tris (pH 7.5), 120 mM KCl, 8 % Ficoll, 4 mM EDTA and 1 mM dithiothreitol for 30 min at room temperature. This reaction was performed by using four different anti-Jun and anti-Fos antibodies (specific cJun antibody, pan Jun family antibody, specific c-Fos antibody and pan Fos family antibody). The epitopes recognized by the pan Jun and pan Fos antibodies correspond to part of the DNA binding domain of the appropriate protein, while the specific cJun and c-Fos antibodies recognize sequences outside the DNA binding domain. End-labelled double-stranded oligonucleotides (1i10& c.p.m.) corresponding to each of the six AP-1 binding sites were added to the nuclear protein\antibody mixture, and the incubation was continued for 30 min at room temperature. The reaction products were resolved by electrophoresis on a 6 % polyacrylamide gel in Tris\borate\EDTA electrophoresis buffer (Digene Diagnostics, Inc., Beltsville, MD, U.S.A.), dried and exposed to Kodak X-Omat film.
mTIMP-3-promoter-luciferase reporter construction
Seven luciferase reporter constructs consisting of 5h deletion fragments of the mTIMP-3 promoter from approx. 0.5 to 2.9 kb were generated by PCR amplification with a 3.4 kb mTIMP-3 genomic clone (containing 2.9 kb of promoter) as the template [22] . The pGL2-Basic luciferase reporter construct (Promega) containing six AP-1 binding sites from the mTIMP-3 promoter was named 6AP, and successive deletions of the 5h end resulted in luciferase reporter constructs containing between five and zero AP-1 binding sites, which were designated 5AP, 4AP, 3AP, 2AP,
Table 2 PCR primers used for construction of mTIMP-3-luciferase reporters
Construct
Designation Primer
1AP and 0AP respectively. The primers used for PCR amplification for the seven luciferase reporter constructs are shown in Table 2 . For 0AP, the PCR fragment was blunt-ended and ligated into pGL2-Basic vector that had been predigested with SmaI. For the other six constructs (6AP to 1AP), the PCR fragment was ligated into pCRII (Invitrogen, San Diego, CA, U.S.A.) and digested with KpnI and XhoI. After purification, the insert was ligated into pGL2-Basic that had been predigested with KpnI and XhoI. Restriction enzyme digestion and DNA sequencing were used to confirm the correct orientation and the absence of PCR-generated mutations in the AP-1 sites.
Transient transfection and transcriptional transactivation assays
JB6 and NIH 3T3 cells were transiently transfected with one of the seven luciferase reporter constructs consisting of the 5h deletion fragment of mTIMP-3 using the calcium phosphate method as described previously [5] . Reporter plasmid DNA at 3.75 µg\well for P − and P + cells and at 1.25 µg\well for NIH 3T3 cells was used to achieve optimal transfection efficiency. For a known AP-1-regulated positive control, the JB6 cells and NIH 3T3 cells were transiently transfected with the construct (GCN) % -luciferase, consisting of four AP-1 sites upstream of the albumin minimal promoter [5] . For a negative control, the empty luciferase vector (pGL2-Basic) was transiently transfected. After a 36 h incubation, the cells were lysed with 0.1 ml of lysis buffer (Promega) for 15 min at room temperature. Luciferase activity was assessed as light emission measured in a Monolight luminometer (Analytic Luminescence Laboratory, San Diego, CA, U.S.A.) and normalized to co-transfected β-galactosidase activity.
Site-directed mutagenesis
This was performed using a site-directed mutagenesis kit (Stratagene). The oligonucleotide primers containing the desired mutation were prepared. These primers, each complementary to opposite strands of the vector, were annealed and extended during temperature cycling by means of Pfu DNA polymerase. On incorporation of the oligonucleotide primers, a mutated plasmid containing staggered nicks was generated. Following temperature cycling, the product was treated with DpnI endonuclease, which is specific for methylated and hemimethylated DNA and was used to digest the parental DNA template and to select for mutation-containing synthesized DNA. The vector DNA incorporating the desired mutation was then transformed into E. coli.
RESULTS
Purified recombinant c-Jun protein binds to all six AP-1 or AP-1-like binding sites in the mTIMP-3 promoter
DNase I footprinting analysis was performed to examine whether the putative AP-1 sites were able to be bound by an AP-1 complex. For this purpose we used purified c-Jun transcription factor, as the low levels of AP-1 components in nuclear extracts prevented us from obtaining clear footprints (results not shown). As shown in Figure 1 , some degree of DNase I protection was observed for all six putative AP-1 sites. Given this observation, we decided to test further the ability of each individual AP-1 site to bind AP-1 in EMSAs using nuclear extracts.
Differential protein binding activities of the six AP-1 or AP-1-like sites in the mTIMP-3 promoter
EMSAs were used to investigate the protein binding activities of the six AP-1-like sites evaluated above. For these assays, nuclear protein extracts were prepared from JB6 P + cells expressing endogenous mTIMP-3. As shown in Figures 2(A) and 2(B) , all six AP-1 sites showed some protein binding, with the AP-1958, AP-763 and AP-720 oligonucleotide binding sites showing the greatest binding activity when P + cell nuclear protein extracts were used. Only the AP-720 complex showed a retardation length identical to that of the SV40 AP-1 control, suggesting a similar protein composition of the two complexes. When the EMSA was carried out using pure c-Jun protein yielding DNAbound Jun\Jun homodimer, only AP-720 showed strong binding activity ( Figure 2C ). Pure c-Jun protein did not bind to the AP-763 oligonucleotide or to AP-1348 or AP-1117, which contain classical AP-1 consensus sequences ( Figure 2C and Table 1 ). When another AP-763 oligonucleotide (5h-ATGTTCTTCTG-GCATGATGTCAC-3h) which contained the AP-1-like sequence (underlines) at the 3h end rather than in the centre was used, no protein binding was observed (results not shown), demonstrating a possible anchoring function of the sequences flanking AP-763. Together, these results indicate that AP-720 has the strongest binding activity for c-Jun protein and that the non-consensus AP-1958, AP-763 and AP-720 sites showed the strongest binding for nuclear proteins.
Given that the major binding in EMSAs was seen with oligonucleotides bearing non-classical AP-1 sites, we investigated whether these sites function as AP-1 sites. Efficient competition by a sequence such as the TRE (TGAGTCA)-containing SV40 sequence known to be regulated by classical Jun\Fos complexes, but not by a mutated SV40 or unrelated sequence, would suggest the possibility of AP-1-like function. This analysis, shown in Figure 3 , utilized non-radioactive competitor oligonucleotides derived from the SV40 AP-1 sequence. As shown in Figure 3 Mutation of the SV40 AP-1 sequence at positions 1 (T) and 6 (C) of the TRE as described in [26] rendered the competition less efficient, but did not abolish it (Figure 3, lower panel) . This suggests a lower binding affinity of the AP-720 binding complex than of the SV40 binding complex for the SV40 site. TRE positions 2-5 and 7, in addition to 1 and 6, appear to contribute to the protein binding activity of AP-720. Possible contributions to binding of SV40 sequences flanking the TRE cannot be excluded. Taken together with the observation that the unrelated NF-κB sequence did not compete (Figure 3 , lower panel), these results suggest that the protein complex(es) binding to AP-720 tolerate some (but not complete) departure from the consensus AP-1 sequence for sequence-specific binding to mTIMP-3 DNA.
To determine whether the DNA binding complexes contained Jun and Fos family proteins, as expected for AP-1 complexes, EMSAs were performed with four different anti-Jun or anti-Fos antibodies (Figure 4 ). AP-763, which showed the strongest binding activity for nuclear protein, and AP-720, which showed in addition binding activity for purified recombinant c-Jun protein, were used for this experiment. Binding of nuclear protein to AP-763 was neither blocked nor supershifted by anti-Jun or anti-Fos antibodies, suggesting that the protein complex bound to AP-763 did not contain Jun or Fos family proteins ( Figure  4A ). In the case of AP-720, binding was completely blocked by pan Jun or pan Fos family antibodies, and showed a small amount of supershifting with the pan Fos family antibody ( Figure 4B ). The DNA binding domains of pan Fos may bind outside the points of DNA-protein contact in these regions, resulting in the lack of complete disruption of the complex following antibody binding. This might explain the supershifted bands seen in addition to the blocked shift obtained with antibody against the DNA binding site. The slight blocking or supershifting observed with the specific c-Jun or c-Fos antibodies ( Figure 4B ) and SV40 AP-1 or AP-720 oligonucleotide may reflect a low 
Deletion analysis of the transcriptional activity of the mTIMP-3 promoter identifies maximal activity for the 2AP construct (k746 to j58)
The 2.9 kb mTIMP-3 promoter contains six AP-1 or AP-1-like elements as well as other sites, all of previously undetermined functional significance. To investigate the functional significance of these AP-1 or AP-1-like elements, as well as that of other regulatory sequences, we constructed luciferase reporters driven by 5h deletion fragments of the mTIMP-3 promoter containing from zero to six AP-1 or AP-1-like sites and binding sites for c-Myc, NF-κB, p53 and other binding proteins. This series of deletion constructs contained from 500 bp to 2.9 kb of the 5h
Figure 4 SV40 AP-1 and AP-720 oligonucleotides show identical patterns of supershifting and blocking with anti-AP-1 antibodies
The protein binding activity of the SV40 AP-1 control sequence was compared with those of the AP-763 oligonucleotide (A) and the AP-720 oligonucleotide (B) by using several anti-Jun or anti-Fos antibodies. As described in the Materials and methods section, nuclear protein from P + (Cl22) cells was incubated with specific c-Jun antibody (c-J), pan Jun family antibody (J), specific c-Fos antibody (c-J) and pan Fos family antibody (F). The same protein was also incubated with the AP-763, AP-720 and SV40 AP-1 oligonucleotides in the absence of antibody (0).
Figure 5 Analysis of 5h deletion constructs shows greatest transcriptional promoter activity for the 2AP construct (k746/j58) containing two AP-1-like sites (AP-720 and AP-617)
JB6 P − cells were transiently transfected with one of the seven luciferase reporter constructs, along with positive (4iAP-1 ; pos.) and negative (pGL2-Basic vector ; vec.) controls, using a calcium phosphate method as described in the Materials and methods section. mTIMP-3 sequence, as shown in Figure 5 . These constructs were transiently transfected into P − JB6 cells, which are known to show endogenous mTIMP-3 expression, and cell lysates were Table 3 
mTIMP-3 promoter luciferase activity
These assays used the same luciferase reporter constructs as with the JB6 P − cells in Figure 5 . 4iAP-1 and pGL2-Basic vector represent positive and negative controls respectively. assayed for luciferase activation. The 2AP construct (k746 to j58), containing both the AP-720 and AP-617 binding sites, showed the greatest promoter activity in P − JB6 cells ( Figure 5 ), suggesting that AP-720 alone or together with AP-617 is important for activating expression of this gene. Increasing the length of the 5h sequence upstream of the AP-720 binding site resulted in decreased promoter activity, suggesting the presence of negative regulatory elements within this region. The transcriptional activity of the mTIMP-3 promoter was the same as or greater than the transcriptional activity of the positive control (4iAP-1), which contains AP-1 but not other transcription factor binding sequences ( Figure 5 ). In addition, the 0AP construct (k491 to j23) showed activity nearly equal to that of the positive control reporter, suggesting that non-AP-1 sites downstream of nucleotide k491 contribute to the activity of the mTIMP-3 promoter. Determinants of maximal activity appear to be located between positions k491 and k746. The transcriptional activity of 2AP (k746), which contains two AP-1 binding sites, was higher than that of 6AP (k2846), which contains six AP-1 binding sites ( Figure 5 ), suggesting that : (i) not all AP-1 or AP-1-like sites contribute to activation of the expression of this gene, and (ii) there are probably negative element(s) in the mTIMP-3 promoter. Transcription factor binding sites for c-Myc and NF-κB have also been identified by sequence inspection of the mTIMP-3 promoter [22] . These binding sites are, however, contained in the 6AP (k2846) construct and are 5h to the sequences contained in 2AP (the most active of the deletion constructs), suggesting that these sites may not contribute significantly to basal transcriptional activity.
We next extended the observations made in P − cells ( Figure 5 ) to JB6 P + cells and to NIH 3T3 cells, both of which also express endogenous mTIMP-3. Once again, 2AP showed the greatest luciferase activity in JB6 P + and NIH 3T3 cells (Table 3) , suggesting the importance of the AP-720 site in mTIMP-3 transcriptional activity. Comparison of the transcriptional activities of these reporter constructs showed a similar rank order among the two JB6 variants and NIH 3T3 cells ( Figure 5 and Table 3 ). Taken together, these results show that the maximal transcriptional activity of the mTIMP-3 promoter, as measured by transient transfection, is associated with the 2AP reporter construct (k746 to j58) containing two AP-1-like sites (AP-720 and AP-617) in both JB6 and NIH 3T3 cells.
To ascertain whether AP-720, AP-617 and\or sequences flanking these elements are responsible for the transcriptional activity of the 2AP mTIMP-3 reporter shown in Figure 5 , several 
AP-720
AP-617 Name of mutant -TCTTAGTCATT--GTTGAATAATT- Table 5 Activity of mTIMP-3 promoter mutants
The constructs are described in Table 4 and Figure 5 . The pGL2-Basic vector is a negative control. constructs with point mutations in the AP-720 and\or AP-617 sites were prepared (Table 4) . Constructs were designed such that no new transcription factor binding sites were generated in the mutated plasmids. The T (position 1 of the TRE) and C (position 6 of the TRE) have been demonstrated to be essential for inducibility by PMA and for protein binding activity [26] . Mutation of the AP-720 sequence decreased mTIMP-3 promoter 2AP activity in P + cells (Table 5 ). This suggested that positions 2-5 and 7, as well as positions 1 and 6, of the TRE sequence and the flanking nucleotide immediately 5h in the AP-720 oligonucleotide contribute to the transcriptional activity of mTIMP-3. The observations that the construct mutated in both AP-720 and AP-617 showed activity similar to that of the construct mutated in AP-720 only, and that these mutant activities were similar to the activity of unmutated 1AP, suggest only a small contribution of AP-617 to the activity of the mTIMP-3 promoter. The relatively high activity of the 0AP construct (also high in Figure 5 and Table 3 ) underscores the conclusion that AP-1-independent events also regulate the mTIMP-3 promoter. It is, nevertheless, clear from these results that the activity increment that distinguishes the 2AP from the 1AP mTIMP-3 reporter construct can be attributed to the AP-1 site at k720 rather than to non-AP-1 flanking sequences.
DISCUSSION
We have recently described the full-length mTIMP-3 cDNA sequence and its transcriptional promoter sequence [22] . Sequence analysis revealed a number of important potential tran-scription factor binding sites. Within this region are six sites for the transcription factor AP-1, two sites for NF-κB, one site for c-Myc and one site for p53 [22] . This large number of potential transcription factor binding sites may indicate a complex mechanism of transcriptional regulation for mTIMP-3. In the present study, regulation of mTIMP-3 expression by AP-1 was investigated by using DNase I footprinting analysis, EMSA and transcriptional activation assays. The results show that, of the six AP-1 binding sites in the mTIMP-3 promoter, AP-720, a nonconsensus AP-1 binding site (5h-TTAGTCA-3h, nt k720 to k714), is important for transcriptional activation and shows the strongest binding activity for c-Jun protein. This result is similar to that for mTIMP-1, in which a non-consensus binding site (5h-TGAGTAA-3h) functions as a strong binding site for Jun\Fos heterodimeric and Jun\Jun homodimeric AP-1 proteins [10] . The explanation for the non-consensus site (AP-720) appearing to be more important for transcriptional activation than the consensus binding sites (AP-1348 and AP-1117) is at present unclear. One possibility may involve the protein-protein interactions that influence DNA binding. Other proteins may be involved in the DNA binding complex that contains Jun and Fos proteins, and this complex may bind with higher affinity to nonconsensus than to consensus AP-1 sites. However, the observation that the non-consensus AP-720 site binds purified cJun more efficiently than the other AP-1 sites suggest that flanking DNA sequences outside of the consensus AP-1 site may have a strong influence on transcription factor binding. Another possibility is that the distance between the various sites and the transcriptional start site may influence transcriptional activity. In addition, the distal AP-1 sites may have a more significant role in the context of the natural chromatin configuration of the gene, whereby DNA bending and chromatin structure may bring these sites in closer proximity to the basal transcriptional machinery.
Like mTIMP-1, which has a transcriptional regulatory element within intron 1 [27] , it is also possible that mTIMP-3 has regulatory element(s) downstream of the transcriptional start site. Although AP-1 transcription factor binding site(s) are critical for transcriptional activation in both mTIMP-1 and mTIMP-3, mTIMP-3 exhibits different functions and has a different pattern of expression [16, [20] [21] [22] [23] [24] , suggesting differences in the mode of regulation. In this respect, hTIMP-3 is a TATA-less gene and has one major transcription start site [18] , while mTIMP-3 has three TATA boxes and multiple transcriptional start sites [22] .
AP-1 binding sites appear to contribute to the basal transcriptional activity of mTIMP-3, as suggested by the observation that mTIMP-3 promoter activity was generally lower in the reporter construct without AP-1 binding sites than in those constructs that contained them (compare 0AP and 2AP). It is clear, however, that significant basal activity occurs independently of AP-1 sites. The similar pattern of activity among the neoplastic and preneoplastic JB6 variants [22] also confirms that the lack of expression of mTIMP-3 in neoplastic JB6 cells is not due to a lack of activated transcription factors.
In summary, we conclude from these observations that AP-1 binding sites in the promoter of the mTIMP-3 gene show differential binding and transcriptional activities, suggesting a role for only a subset of AP-1 sites, principally the k720 site, in Received 22 August 1996/30 January 1997 ; accepted 30 January 1997 the positive regulation of mTIMP-3 expression. The function of these sites does not correlate directly with the extent of similarity to the published AP-1 consensus sequence. It is noteworthy, however, that the site associated with both highest activity and high specific binding appears to be occupied exclusively by complexes containing Jun and Fos family proteins. The control of expression of mTIMP-3 is likely to be complex and to involve multiple non-AP-1 regulatory elements as well. Further investigations are under way to elucidate the role of these non-AP-1 elements, especially those immediately 5h or 3h to the transcriptional start site.
